BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10733478)

  • 1. Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.
    García-Carrasco M; Pizcueta P; Cervera R; Ramos-Casals M; Sisó A; de La Red G; Ingelmo M; Font J; Engel P
    Ann Rheum Dis; 2000 Apr; 59(4):297-9. PubMed ID: 10733478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.
    García-Carrasco M; Sisó A; Ramos-Casals M; Rosas J; de la Red G; Gil V; Lasterra S; Cervera R; Font J; Ingelmo M
    J Rheumatol; 2002 Apr; 29(4):726-30. PubMed ID: 11950013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome.
    Ramos-Casals M; Font J; García-Carrasco M; Calvo J; Places L; Padilla O; Cervera R; Bowen MA; Lozano F; Ingelmo M
    Rheumatology (Oxford); 2001 Sep; 40(9):1056-9. PubMed ID: 11561119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) and neopterin in patients with Sjögren's syndrome.
    Andrýs C; Krejsek J; Slezák R; Drahosová M; Kopecký O
    Acta Medica (Hradec Kralove); 1999; 42(3):97-101. PubMed ID: 10677896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren's syndrome.
    Kabeerdoss J; Sandhya P; Mandal SK; Gowri M; Danda D
    Clin Rheumatol; 2016 Dec; 35(12):3063-3067. PubMed ID: 27620619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome.
    Fujihara T; Takeuchi T; Tsubota K; Kayagaki N; Yagita H; Okumura K; Abe T
    Clin Rheumatol; 1998; 17(6):496-9. PubMed ID: 9890678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CXCL4 increase in primary Sjögren's syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement.
    Vettori S; Irace R; Riccardi A; Iacono D; Pellecchia L; Vicedomini L; Valentini G
    Clin Rheumatol; 2016 Oct; 35(10):2591-6. PubMed ID: 27562035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of soluble CD44 in primary Sjögren's syndrome.
    Levesque MC; Mackin DA; Fleming JA; St Clair EW
    J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjögren's syndrome.
    Yan S; Li M; Wang H; Yang X; Zhao J; Wang Q; Liu Y; Lai J; Tian Z; Song H; Zhao Y; Zeng X
    Int J Rheum Dis; 2018 May; 21(5):1068-1075. PubMed ID: 29624870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are there clinical or serological differences between male and female patients with primary Sjögren's syndrome?
    Díaz-López C; Geli C; Corominas H; Malat N; Diaz-Torner C; Llobet JM; De La Serna AR; Laiz A; Moreno M; Vázquez G
    J Rheumatol; 2004 Jul; 31(7):1352-5. PubMed ID: 15229956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE).
    Font J; Pizcueta P; Ramos-Casals M; Cervera R; García-Carrasco M; Navarro M; Ingelmo M; Engel P
    Clin Exp Immunol; 2000 Jan; 119(1):169-74. PubMed ID: 10606979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-centromere antibody-positive Sjögren's syndrome: A distinct clinical subgroup?
    Lee KE; Kang JH; Lee JW; Wen L; Park DJ; Kim TJ; Park YW; Lee SS
    Int J Rheum Dis; 2015 Sep; 18(7):776-82. PubMed ID: 26179502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.
    Hebbar M; Lassalle P; Delneste Y; Hatron PY; Devulder B; Tonnel AB; Janin A
    Ann Rheum Dis; 1997 Apr; 56(4):230-4. PubMed ID: 9165994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
    Tunc R; Gonen MS; Acbay O; Hamuryudan V; Yazici H
    Ann Rheum Dis; 2004 May; 63(5):575-7. PubMed ID: 15082490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome.
    Youinou P; Pennec YL; Casburn-Budd R; Dueymes M; Letoux G; Lamour A
    J Autoimmun; 1992 Jun; 5(3):393-400. PubMed ID: 1388642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.